3-(2,2,2-TRIFLUOROETHYL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE, 95.0%, 1g

citrato de trilitio tetrahidratado, mínimo 98 %, Ph.Eur., 500 g, envase de plástico.

n-(6-Methoxypyridin-3-yl)acetamide, 95%, 1g

1,2,3,5-Tetrafluorobenzene, 97.0%, 10g

(1R*,4R*)-N1-(Tetrahydro-2H-pyran-4-yl)cyclohexane-1,4-diamine dihydrochloride, 1g

2-Fluoroquinoline, 95.0%, 5g

1-Aminocyclopropanecarboxamide, 95.0%, 10g

Methyl 3-Methyl-2-nitrobenzoate, 97.0%, 100g

Methyl 2-formylbenzoate, 95.0%, 10g

tert-Butyl 4-(4-bromophenyl)piperazine-1-carboxylate, 95.0%, 100g

Ethyl 6-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate, 97.0%, 1g

methyl 5-fluoro-1H-pyrrolo[2,3-b]pyridine-4-carboxylate, 95.0%, 100mg

5-Hydroxymethyl-1H-pyridin-2-one, 95.0%, 1g